Kidney tissue study during liver transplant
Part of Digestive system, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at kidney tissue from patients having a liver transplant to understand and improve treatment for a kidney problem called hepatorenal syndrome. It may help doctors find better ways to protect kidney function after transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are scheduled to receive a liver transplant.
- You have been diagnosed with hepatorenal syndrome (a kidney problem linked to liver disease).
- You do not have pre-existing kidney disease or a single kidney.
- You are willing to have a small kidney tissue sample taken during the transplant and again 3 months later.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who are getting a liver transplant (including repeat transplants) to monitor changes in their body using test results. It may help doctors understand how patients are doing after transplant and improve care over time.
This trial studies kidney biopsies in people who had a liver transplant and then developed new signs of kidney damage. The goal is to better understand what’s causing the problem and how to guide next steps.
This study looks at kidney transplant patients to better predict long-term outcomes by examining small samples of kidney tissue (biopsies). It may help doctors understand why some transplants succeed and others don't, potentially improving care.
This study looks at gene activity inside kidney tissue to better understand how transplanted kidneys work. Researchers will collect blood, urine, stool, and tiny pieces of kidney tissue over time to see what happens after a transplant.
This study will collect blood samples from people having a kidney biopsy or a kidney transplant to look for biomarkers (biological signs) that can give doctors more information about kidney health. Participating may help doctors better understand and treat kidney disease in the future.
This trial collects and stores health information and samples related to kidney transplants from both donors and recipients. It may help researchers better understand transplant outcomes and improve care in the future.
Hear when a new Liver Transplant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.